Financial hardship can persist long after treatment ends. Here is how survivorship programs can identify risk, connect survivors with appropriate support, and track follow-through without creating another labor-intensive workflow.
For many cancer survivors, treatment ends before the financial consequences do.
Copayments, deductibles, medications, surveillance imaging, rehabilitation, follow-up visits, transportation, and time away from work can continue well beyond the acute treatment period. Some survivors also experience reduced income, job disruption, loss of benefits, or new costs associated with managing long-term and late effects.
The National Cancer Institute uses the term financial toxicity to describe the financial problems and distress that can result from the cost of cancer care. Importantly for survivorship programs, NCI notes that survivors can experience financial problems many years after diagnosis because of ongoing care and treatment-related late effects.
Financial toxicity therefore should not be viewed only as an issue for patients receiving chemotherapy or radiation. It is a survivorship issue that health systems increasingly need a structured way to identify and address.
Why Financial Toxicity Belongs in Survivorship Care
Financial hardship after cancer is not limited to medical bills. It can include lost income, reduced working hours, difficulty maintaining insurance, debt, trouble paying for housing or food, and anxiety about future costs. NCI’s professional guidance describes financial toxicity as a combination of material burden, income disruption, and psychological distress. It also notes that cancer survivors generally have higher out-of-pocket expenses than people without a cancer history and may experience lasting effects on employment and productivity.
These pressures can interact with other survivorship concerns.
A recent longitudinal study published in JCO Oncology Practice followed patients with cancer over six months and found that greater financial toxicity was associated with lower health-related quality of life and higher psychological distress. The authors also found that access to a financial counselor was associated with lower financial toxicity among patients who wanted a referral. Because the cohort included many patients already seeking financial assistance, its prevalence estimates should not be generalized to every cancer population. The relationship between financial burden, quality of life, and distress, however, reinforces why financial concerns should be considered part of whole-person cancer care.
The National Standards for Cancer Survivorship Care make this expectation explicit. They state that survivors should be assessed for financial hardship or toxicity and concerns about insurance coverage, then provided resources and support when needed. The same standards also recommend assessing practical and social needs such as employment and return to work.
For survivorship leaders, the question is increasingly not whether financial toxicity matters, but how to address it reliably at scale.
Why a One-Time Financial Screen Is Not Enough
Many cancer programs already ask about financial concerns during diagnosis or treatment. The challenge is that financial risk changes over time.
A patient may be financially stable during treatment because of paid leave but struggle when those benefits expire. Someone who initially has minimal out-of-pocket costs may later face expensive surveillance, medications, rehabilitation, or specialty care. A survivor may return to work but discover that fatigue, cognitive changes, neuropathy, or other late effects make it difficult to maintain previous hours or responsibilities.
Financial toxicity is therefore better understood as a changing risk rather than a fixed characteristic.
The 2026 JCO Oncology Practice longitudinal study specifically recommended repeated financial-toxicity screening across the cancer-care continuum.
That approach also aligns with the broader structure of NCI’s survivorship standards, which emphasize repeated assessment of physical, psychosocial, and practical needs during follow-up rather than a single post-treatment evaluation.
For health systems, repeated screening does not have to mean adding a lengthy financial interview to every visit. Short digital assessments can identify people whose circumstances have changed and route only those patients who need additional help to a navigator, social worker, financial counselor, or community resource.
What Should Health Systems Screen For?
Financial screening should capture more than a patient’s income.
Useful signals may include difficulty paying medical bills, concerns about insurance coverage, medication affordability, changes in employment, inability to work because of health, transportation or lodging costs, food or housing insecurity, and worry about future healthcare expenses.
Validated tools can help standardize this assessment. One commonly studied measure is the Comprehensive Score for Financial Toxicity, or COST, which assesses the financial distress associated with cancer care.
A 2026 quality-improvement project published by the Oncology Nursing Society used COST screening in a rural oncology clinic and referred patients meeting the program’s risk threshold to a lay financial navigator. ONS reported that early screening identified previously hidden financial distress and that the navigator model was feasible in that setting. The specific cutoff used in the project should not automatically be adopted by every organization; screening thresholds and referral protocols should be defined locally based on the instrument, patient population, and available services.
The larger lesson is operational: screening works best when a positive result leads somewhere.
A Practical Five-Step Financial Toxicity Pathway
A scalable model can be built around five connected steps: identify, stratify, route, follow up, and reassess.
First, health systems can embed a short financial-needs assessment at clinically meaningful points in survivorship. Examples include completion of first-course treatment, entry into a survivorship program, major changes in therapy, annual follow-up, or a significant change in employment or insurance.
Second, responses can be stratified by level and type of need. A survivor looking for basic information about insurance or workplace accommodations may not require the same intervention as someone who is unable to afford medication or is facing food or housing insecurity.
Third, each level of need should map to a defined resource. Lower-intensity concerns may be addressed with trusted educational resources, benefits information, employer or disability guidance, or community programs. More complex cases may require a financial navigator, oncology social worker, patient assistance specialist, or other member of the health system’s support team.
Fourth, the program should capture whether the survivor actually connected with the recommended resource. A referral alone does not tell the organization whether the underlying barrier was addressed.
Finally, financial risk should be reassessed periodically. A survivor who needs no assistance today may require substantial support six months later.
This model closely mirrors the NCI survivorship standards, which call for defined multidisciplinary referral workflows, support based on survivor needs, longitudinal data collection, and measurement of referral and completion rates.
Financial Navigation Does Not Have to Become Another Full-Time Job
The concern many cancer programs will immediately raise is capacity.
Oncology nurses, navigators, social workers, and supportive-care teams are already managing high workloads. Adding another screening requirement can be counterproductive if every positive response creates manual outreach, documentation, and tracking.
The solution is to separate screening and routine support from specialized intervention.
Technology can administer brief assessments, provide standardized educational resources, surface local support options, send follow-up prompts, and document whether a survivor engaged with the recommended resource. Human staff can then focus on the patients whose responses indicate a meaningful barrier or who require individualized financial navigation.
This is also where survivorship programs can use external or community resources rather than attempting to build every service internally. NCI’s standards explicitly allow survivorship care to be provided on-site, through telehealth, or by referral and emphasize defined workflows between team members and support services.
A scalable financial-toxicity pathway is therefore less about hiring a new specialist for every need and more about creating a reliable system that directs the right survivor to the right level of support.
What Should Health Systems Measure?
Programs should resist measuring success only by how many financial referrals were placed.
More useful measures include the percentage of eligible survivors screened, the proportion who report financial concerns, the types of needs identified, referral or resource utilization, time from screening to connection with support, referral completion, and reasons survivors do not engage.
Organizations may also monitor related outcomes such as employment or return-to-work status, patient-reported quality of life, distress, and experience of care.
These measures align with NCI’s survivorship framework, which recommends that organizations collect patient-reported outcomes, functional measures, return-to-work information, referral completion, and relevant business metrics when evaluating survivorship programs.
Over time, these data can help leaders identify patterns that would otherwise remain invisible. A program may discover, for example, that medication affordability is the dominant issue for one population while transportation or employment disruption is more significant for another.
That information allows survivorship services to become increasingly targeted rather than simply larger.
Where Digital Survivorship Support Can Help
A digital survivorship platform should not replace financial counselors, social workers, navigators, or clinical judgment.
Its role is to make the surrounding workflow easier to deliver consistently.
At The After Cancer, the broader objective is to give health systems a scalable delivery and coordination layer for survivorship care. Digital assessments, personalized resources, structured pathways, ongoing engagement, and centralized reporting can help organizations identify needs between visits and direct survivors toward appropriate internal or community services without requiring clinicians to manually deliver every routine interaction. This type of model complements rather than replaces existing supportive-care teams.
Financial toxicity is a particularly good example of why that infrastructure matters. The problem may first surface long after a traditional treatment-ending visit. Without repeated contact or structured assessment, the health system may never know that the survivor is struggling.
Financial Recovery Is Part of Recovery After Cancer
Cancer survivorship care has traditionally focused heavily on surveillance, recurrence risk, and treatment-related symptoms. Those responsibilities remain essential.
But living well after cancer also means being able to work, afford ongoing healthcare, maintain insurance, meet basic needs, and make decisions without financial distress shaping every choice.
Current survivorship standards increasingly recognize that reality. Financial hardship is not separate from health; it is one of the practical consequences of cancer that survivorship programs should be prepared to identify and address.
Health systems do not need to solve every financial problem themselves. They do need a reliable way to detect risk, guide survivors toward appropriate help, confirm whether support was reached, and reassess as circumstances change.
That is the difference between offering a resource and building a survivorship pathway.
If your cancer program is exploring how to expand whole-person survivorship support while minimizing additional operational burden, The After Cancer can help you evaluate how digital screening, personalized pathways, and engagement tracking could complement your existing services. Book a conversation with our team to learn more.
Sources
National Cancer Institute — Financial Toxicity and Cancer Treatment, Health Professional Version
National Cancer Institute — National Standards for Cancer Survivorship Care